OptimizeRx names Sarah Bast as chief marketing officer

OptimizeRx Corp. (Nasdaq: OPRX) has appointed Sarah Bast as chief marketing officer, the Waltham, Massachusetts-based healthcare technology company announced July 23, 2026.

Bast brings more than two decades of pharmaceutical marketing experience to the role, with a background in point-of-care media strategy, analytics, and optimization. She most recently served as executive vice president of investment marketplace at Publicis Health Media, where she developed partnerships and solutions spanning point-of-care media, electronic health records, and telehealth.

During her career, Bast worked with life sciences companies including Lilly, Bayer, Johnson & Johnson, and AstraZeneca.

In her new role, Bast will oversee OptimizeRx's marketing strategy, brand positioning, and go-to-market initiatives, with a focus on relationships with healthcare marketing agencies and in-house life sciences marketing teams.

"OptimizeRx is one of the foundational partners in the point of care space, with a proven track record of enabling pharma brands to engage healthcare providers at the moments that matter most, and I'm excited to help shape what's next," Bast said.

Chief Executive Officer Steve Silvestro said in a statement that Bast "has spent her career helping life sciences brands solve complex marketing challenges and understands firsthand how healthcare marketers can reach providers more effectively."

You May Also Be Interested In

• Datavault AI names Frank Deo CTO of its Acoustic Sciences Division
• Robin Energy prices $3M stock offering at $4.00 per share
• Merck signs HIV prevention drug licenses covering 129 countries